jCyte Announces Appointment of R. Heath Coats as Vice President of CMC, Regulatory Compliance and Quality Control

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--jCyte, Inc., a private biotechnology company dedicated to improving the lives of patients with retinal degenerative diseases, announced the expansion of the company’s leadership team with the appointment of R. Heath Coats as Vice President of CMC, Regulatory Compliance and Quality Control. In his new role, Mr. Coats will be the strategic and technical lead for manufacturing design, technology transfer, analytical test development, quality control, drug pr

Full Story →